Mpox outbreak study in the Democratic Republic of Congo
Part of Infections clinical trials.
This study is for people in the Democratic Republic of Congo who have been diagnosed with mpox. Researchers want to learn more about how the virus spreads and how it affects people during this outbreak.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a lab test (like a PCR test) that confirmed you have mpox.
- You must have deep-seated, firm blisters or pustules on your skin.
- You must have had at least one of these: fever before the rash appeared, swollen lymph nodes (in the groin, armpit, or neck), or pustules on the palms of your hands or soles of your feet.
- You (or someone you trust) must agree to participate and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine designed to protect against smallpox and mpox. It aims to see if the vaccine is safe and triggers a good immune response in people aged 2 to 45.
This study tests people for VMPX to learn more about the condition and to understand how it affects the body. You can join if you are willing to be tested and can give permission.
This study follows people who are getting a booster dose of the MVA-BN vaccine, which is used to protect against mpox. The goal is to see how the booster works and monitor any side effects.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
Hear when a new Monkeypox (Mpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.